nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvastatin—UGT2B7—Epirubicin—sarcoma	0.15	0.188	CbGbCtD
Fluvastatin—CYP2B6—Thiotepa—sarcoma	0.144	0.18	CbGbCtD
Fluvastatin—CYP1A1—Dacarbazine—sarcoma	0.105	0.131	CbGbCtD
Fluvastatin—UGT1A1—Etoposide—sarcoma	0.101	0.126	CbGbCtD
Fluvastatin—CYP1A2—Dacarbazine—sarcoma	0.0468	0.0585	CbGbCtD
Fluvastatin—CYP3A4—Thiotepa—sarcoma	0.0442	0.0554	CbGbCtD
Fluvastatin—CYP3A5—Vincristine—sarcoma	0.0336	0.042	CbGbCtD
Fluvastatin—CYP3A5—Etoposide—sarcoma	0.0308	0.0385	CbGbCtD
Fluvastatin—CYP2C8—Etoposide—sarcoma	0.0296	0.037	CbGbCtD
Fluvastatin—CYP2B6—Doxorubicin—sarcoma	0.0266	0.0333	CbGbCtD
Fluvastatin—CYP1A2—Etoposide—sarcoma	0.0229	0.0286	CbGbCtD
Fluvastatin—CYP3A4—Mitoxantrone—sarcoma	0.019	0.0238	CbGbCtD
Fluvastatin—CYP3A4—Vincristine—sarcoma	0.0131	0.0164	CbGbCtD
Fluvastatin—CYP2D6—Doxorubicin—sarcoma	0.0129	0.0161	CbGbCtD
Fluvastatin—CYP3A4—Etoposide—sarcoma	0.012	0.015	CbGbCtD
Fluvastatin—CYP3A4—Doxorubicin—sarcoma	0.00818	0.0102	CbGbCtD
Fluvastatin—SLCO1B1—mammary gland—sarcoma	0.0013	0.0441	CbGeAlD
Fluvastatin—SLCO2B1—mammary gland—sarcoma	0.00115	0.039	CbGeAlD
Fluvastatin—UGT1A3—liver—sarcoma	0.00101	0.0342	CbGeAlD
Fluvastatin—HMGCR—myometrium—sarcoma	0.000961	0.0326	CbGeAlD
Fluvastatin—UGT1A1—hematopoietic system—sarcoma	0.00095	0.0323	CbGeAlD
Fluvastatin—HMGCR—seminal vesicle—sarcoma	0.000868	0.0295	CbGeAlD
Fluvastatin—HMGCR—hematopoietic system—sarcoma	0.000825	0.028	CbGeAlD
Fluvastatin—HMGCR—connective tissue—sarcoma	0.000794	0.027	CbGeAlD
Fluvastatin—SLCO1B1—hematopoietic system—sarcoma	0.00079	0.0268	CbGeAlD
Fluvastatin—CYP2C8—mammary gland—sarcoma	0.000738	0.0251	CbGeAlD
Fluvastatin—HMGCR—smooth muscle tissue—sarcoma	0.000727	0.0247	CbGeAlD
Fluvastatin—HMGCR—skin of body—sarcoma	0.000717	0.0244	CbGeAlD
Fluvastatin—SLCO1B3—liver—sarcoma	0.000708	0.024	CbGeAlD
Fluvastatin—SLCO2B1—hematopoietic system—sarcoma	0.000699	0.0237	CbGeAlD
Fluvastatin—CYP2C9—mammary gland—sarcoma	0.000655	0.0223	CbGeAlD
Fluvastatin—HMGCR—cardiac atrium—sarcoma	0.000627	0.0213	CbGeAlD
Fluvastatin—HMGCR—uterus—sarcoma	0.000623	0.0212	CbGeAlD
Fluvastatin—UGT2B7—testis—sarcoma	0.000612	0.0208	CbGeAlD
Fluvastatin—HMGCR—lymphoid tissue—sarcoma	0.000581	0.0197	CbGeAlD
Fluvastatin—UGT2B7—liver—sarcoma	0.000579	0.0197	CbGeAlD
Fluvastatin—HMGCR—tendon—sarcoma	0.000546	0.0185	CbGeAlD
Fluvastatin—HMGCR—bone marrow—sarcoma	0.000529	0.018	CbGeAlD
Fluvastatin—SLCO2B1—uterus—sarcoma	0.000528	0.0179	CbGeAlD
Fluvastatin—CYP2C19—hematopoietic system—sarcoma	0.000515	0.0175	CbGeAlD
Fluvastatin—UGT1A1—liver—sarcoma	0.000492	0.0167	CbGeAlD
Fluvastatin—SLCO2B1—tendon—sarcoma	0.000463	0.0157	CbGeAlD
Fluvastatin—HMGCR—testis—sarcoma	0.000452	0.0154	CbGeAlD
Fluvastatin—CYP2C8—hematopoietic system—sarcoma	0.000449	0.0153	CbGeAlD
Fluvastatin—SLC15A1—liver—sarcoma	0.000442	0.015	CbGeAlD
Fluvastatin—HMGCR—liver—sarcoma	0.000427	0.0145	CbGeAlD
Fluvastatin—CYP1A2—hematopoietic system—sarcoma	0.000421	0.0143	CbGeAlD
Fluvastatin—CYP1A1—hematopoietic system—sarcoma	0.000415	0.0141	CbGeAlD
Fluvastatin—SLCO1B1—liver—sarcoma	0.00041	0.0139	CbGeAlD
Fluvastatin—CYP3A5—hematopoietic system—sarcoma	0.000406	0.0138	CbGeAlD
Fluvastatin—CYP2B6—hematopoietic system—sarcoma	0.000403	0.0137	CbGeAlD
Fluvastatin—CYP2C9—hematopoietic system—sarcoma	0.000399	0.0136	CbGeAlD
Fluvastatin—SLCO2B1—testis—sarcoma	0.000383	0.013	CbGeAlD
Fluvastatin—SLCO2B1—liver—sarcoma	0.000362	0.0123	CbGeAlD
Fluvastatin—CYP1A1—skin of body—sarcoma	0.000361	0.0123	CbGeAlD
Fluvastatin—CYP2B6—skin of body—sarcoma	0.000351	0.0119	CbGeAlD
Fluvastatin—Constipation—Mitoxantrone—sarcoma	0.000334	0.00195	CcSEcCtD
Fluvastatin—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000334	0.00195	CcSEcCtD
Fluvastatin—Hypersensitivity—Thiotepa—sarcoma	0.000334	0.00195	CcSEcCtD
Fluvastatin—Nasopharyngitis—Epirubicin—sarcoma	0.000332	0.00194	CcSEcCtD
Fluvastatin—Face oedema—Doxorubicin—sarcoma	0.000331	0.00194	CcSEcCtD
Fluvastatin—Hypersensitivity—Dactinomycin—sarcoma	0.000331	0.00193	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Vincristine—sarcoma	0.000328	0.00192	CcSEcCtD
Fluvastatin—Gastritis—Epirubicin—sarcoma	0.000328	0.00192	CcSEcCtD
Fluvastatin—Confusional state—Etoposide—sarcoma	0.000328	0.00192	CcSEcCtD
Fluvastatin—HMGCR—lymph node—sarcoma	0.000328	0.0111	CbGeAlD
Fluvastatin—Muscular weakness—Epirubicin—sarcoma	0.000327	0.00191	CcSEcCtD
Fluvastatin—Anaphylactic shock—Etoposide—sarcoma	0.000325	0.0019	CcSEcCtD
Fluvastatin—Asthenia—Thiotepa—sarcoma	0.000325	0.0019	CcSEcCtD
Fluvastatin—Infection—Etoposide—sarcoma	0.000323	0.00189	CcSEcCtD
Fluvastatin—Asthenia—Dactinomycin—sarcoma	0.000322	0.00188	CcSEcCtD
Fluvastatin—Feeling abnormal—Mitoxantrone—sarcoma	0.000322	0.00188	CcSEcCtD
Fluvastatin—Influenza—Epirubicin—sarcoma	0.000321	0.00187	CcSEcCtD
Fluvastatin—Pruritus—Thiotepa—sarcoma	0.00032	0.00187	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00032	0.00187	CcSEcCtD
Fluvastatin—Thrombocytopenia—Etoposide—sarcoma	0.000319	0.00186	CcSEcCtD
Fluvastatin—Eosinophilia—Epirubicin—sarcoma	0.000317	0.00185	CcSEcCtD
Fluvastatin—Body temperature increased—Vincristine—sarcoma	0.000317	0.00185	CcSEcCtD
Fluvastatin—Abdominal pain—Vincristine—sarcoma	0.000317	0.00185	CcSEcCtD
Fluvastatin—Skin disorder—Etoposide—sarcoma	0.000316	0.00185	CcSEcCtD
Fluvastatin—CYP1A1—cardiac atrium—sarcoma	0.000315	0.0107	CbGeAlD
Fluvastatin—Hyperhidrosis—Etoposide—sarcoma	0.000314	0.00184	CcSEcCtD
Fluvastatin—Pancreatitis—Epirubicin—sarcoma	0.000314	0.00184	CcSEcCtD
Fluvastatin—Abdominal pain upper—Doxorubicin—sarcoma	0.000314	0.00183	CcSEcCtD
Fluvastatin—CYP1A1—uterus—sarcoma	0.000313	0.0106	CbGeAlD
Fluvastatin—Urticaria—Mitoxantrone—sarcoma	0.000311	0.00181	CcSEcCtD
Fluvastatin—Breast disorder—Doxorubicin—sarcoma	0.00031	0.00181	CcSEcCtD
Fluvastatin—Anorexia—Etoposide—sarcoma	0.00031	0.00181	CcSEcCtD
Fluvastatin—Diarrhoea—Thiotepa—sarcoma	0.00031	0.00181	CcSEcCtD
Fluvastatin—Abdominal pain—Mitoxantrone—sarcoma	0.000309	0.00181	CcSEcCtD
Fluvastatin—Body temperature increased—Mitoxantrone—sarcoma	0.000309	0.00181	CcSEcCtD
Fluvastatin—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000309	0.00181	CcSEcCtD
Fluvastatin—Bronchitis—Epirubicin—sarcoma	0.000308	0.0018	CcSEcCtD
Fluvastatin—Diarrhoea—Dactinomycin—sarcoma	0.000308	0.0018	CcSEcCtD
Fluvastatin—Nasopharyngitis—Doxorubicin—sarcoma	0.000307	0.00179	CcSEcCtD
Fluvastatin—CYP3A4—hematopoietic system—sarcoma	0.000304	0.0103	CbGeAlD
Fluvastatin—Gastritis—Doxorubicin—sarcoma	0.000304	0.00177	CcSEcCtD
Fluvastatin—Muscular weakness—Doxorubicin—sarcoma	0.000303	0.00177	CcSEcCtD
Fluvastatin—CYP2D6—hematopoietic system—sarcoma	0.0003	0.0102	CbGeAlD
Fluvastatin—Dizziness—Thiotepa—sarcoma	0.000299	0.00175	CcSEcCtD
Fluvastatin—Upper respiratory tract infection—Epirubicin—sarcoma	0.000298	0.00174	CcSEcCtD
Fluvastatin—Influenza—Doxorubicin—sarcoma	0.000297	0.00173	CcSEcCtD
Fluvastatin—Hypersensitivity—Vincristine—sarcoma	0.000296	0.00173	CcSEcCtD
Fluvastatin—Eosinophilia—Doxorubicin—sarcoma	0.000294	0.00172	CcSEcCtD
Fluvastatin—Photosensitivity reaction—Epirubicin—sarcoma	0.000293	0.00171	CcSEcCtD
Fluvastatin—Paraesthesia—Etoposide—sarcoma	0.000292	0.00171	CcSEcCtD
Fluvastatin—Pancreatitis—Doxorubicin—sarcoma	0.000291	0.0017	CcSEcCtD
Fluvastatin—Dyspnoea—Etoposide—sarcoma	0.00029	0.00169	CcSEcCtD
Fluvastatin—Hypersensitivity—Mitoxantrone—sarcoma	0.000288	0.00168	CcSEcCtD
Fluvastatin—Asthenia—Vincristine—sarcoma	0.000288	0.00168	CcSEcCtD
Fluvastatin—Vomiting—Thiotepa—sarcoma	0.000288	0.00168	CcSEcCtD
Fluvastatin—Infestation—Epirubicin—sarcoma	0.000286	0.00167	CcSEcCtD
Fluvastatin—Infestation NOS—Epirubicin—sarcoma	0.000286	0.00167	CcSEcCtD
Fluvastatin—Vomiting—Dactinomycin—sarcoma	0.000286	0.00167	CcSEcCtD
Fluvastatin—Rash—Thiotepa—sarcoma	0.000286	0.00167	CcSEcCtD
Fluvastatin—Bronchitis—Doxorubicin—sarcoma	0.000285	0.00167	CcSEcCtD
Fluvastatin—Dermatitis—Thiotepa—sarcoma	0.000285	0.00167	CcSEcCtD
Fluvastatin—CYP2B6—lymphoid tissue—sarcoma	0.000284	0.00964	CbGeAlD
Fluvastatin—Headache—Thiotepa—sarcoma	0.000284	0.00166	CcSEcCtD
Fluvastatin—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000283	0.00166	CcSEcCtD
Fluvastatin—Rash—Dactinomycin—sarcoma	0.000283	0.00166	CcSEcCtD
Fluvastatin—Decreased appetite—Etoposide—sarcoma	0.000283	0.00165	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Etoposide—sarcoma	0.000281	0.00164	CcSEcCtD
Fluvastatin—Asthenia—Mitoxantrone—sarcoma	0.000281	0.00164	CcSEcCtD
Fluvastatin—Fatigue—Etoposide—sarcoma	0.00028	0.00164	CcSEcCtD
Fluvastatin—Neuropathy peripheral—Epirubicin—sarcoma	0.00028	0.00164	CcSEcCtD
Fluvastatin—Constipation—Etoposide—sarcoma	0.000278	0.00162	CcSEcCtD
Fluvastatin—Pain—Etoposide—sarcoma	0.000278	0.00162	CcSEcCtD
Fluvastatin—Urinary tract infection—Epirubicin—sarcoma	0.000278	0.00162	CcSEcCtD
Fluvastatin—Conjunctivitis—Epirubicin—sarcoma	0.000278	0.00162	CcSEcCtD
Fluvastatin—SLCO2B1—lymph node—sarcoma	0.000278	0.00943	CbGeAlD
Fluvastatin—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000276	0.00161	CcSEcCtD
Fluvastatin—Diarrhoea—Vincristine—sarcoma	0.000275	0.0016	CcSEcCtD
Fluvastatin—Sweating—Epirubicin—sarcoma	0.000274	0.0016	CcSEcCtD
Fluvastatin—Photosensitivity reaction—Doxorubicin—sarcoma	0.000271	0.00158	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Epirubicin—sarcoma	0.00027	0.00158	CcSEcCtD
Fluvastatin—Nausea—Thiotepa—sarcoma	0.000269	0.00157	CcSEcCtD
Fluvastatin—Sinusitis—Epirubicin—sarcoma	0.000268	0.00157	CcSEcCtD
Fluvastatin—Feeling abnormal—Etoposide—sarcoma	0.000268	0.00157	CcSEcCtD
Fluvastatin—Diarrhoea—Mitoxantrone—sarcoma	0.000268	0.00156	CcSEcCtD
Fluvastatin—Nausea—Dactinomycin—sarcoma	0.000267	0.00156	CcSEcCtD
Fluvastatin—CYP2C19—liver—sarcoma	0.000267	0.00906	CbGeAlD
Fluvastatin—Gastrointestinal pain—Etoposide—sarcoma	0.000266	0.00155	CcSEcCtD
Fluvastatin—Dizziness—Vincristine—sarcoma	0.000266	0.00155	CcSEcCtD
Fluvastatin—Infestation—Doxorubicin—sarcoma	0.000265	0.00154	CcSEcCtD
Fluvastatin—Infestation NOS—Doxorubicin—sarcoma	0.000265	0.00154	CcSEcCtD
Fluvastatin—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000262	0.00153	CcSEcCtD
Fluvastatin—Neuropathy peripheral—Doxorubicin—sarcoma	0.000259	0.00151	CcSEcCtD
Fluvastatin—Urticaria—Etoposide—sarcoma	0.000258	0.00151	CcSEcCtD
Fluvastatin—Rhinitis—Epirubicin—sarcoma	0.000257	0.0015	CcSEcCtD
Fluvastatin—Body temperature increased—Etoposide—sarcoma	0.000257	0.0015	CcSEcCtD
Fluvastatin—Abdominal pain—Etoposide—sarcoma	0.000257	0.0015	CcSEcCtD
Fluvastatin—Conjunctivitis—Doxorubicin—sarcoma	0.000257	0.0015	CcSEcCtD
Fluvastatin—Urinary tract infection—Doxorubicin—sarcoma	0.000257	0.0015	CcSEcCtD
Fluvastatin—Hepatitis—Epirubicin—sarcoma	0.000257	0.0015	CcSEcCtD
Fluvastatin—Hypoaesthesia—Epirubicin—sarcoma	0.000255	0.00149	CcSEcCtD
Fluvastatin—Vomiting—Vincristine—sarcoma	0.000255	0.00149	CcSEcCtD
Fluvastatin—Pharyngitis—Epirubicin—sarcoma	0.000255	0.00149	CcSEcCtD
Fluvastatin—Sweating—Doxorubicin—sarcoma	0.000254	0.00148	CcSEcCtD
Fluvastatin—Rash—Vincristine—sarcoma	0.000253	0.00148	CcSEcCtD
Fluvastatin—Dermatitis—Vincristine—sarcoma	0.000253	0.00148	CcSEcCtD
Fluvastatin—Oedema peripheral—Epirubicin—sarcoma	0.000253	0.00148	CcSEcCtD
Fluvastatin—Connective tissue disorder—Epirubicin—sarcoma	0.000252	0.00147	CcSEcCtD
Fluvastatin—Headache—Vincristine—sarcoma	0.000252	0.00147	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Doxorubicin—sarcoma	0.00025	0.00146	CcSEcCtD
Fluvastatin—Vomiting—Mitoxantrone—sarcoma	0.000249	0.00145	CcSEcCtD
Fluvastatin—Sinusitis—Doxorubicin—sarcoma	0.000248	0.00145	CcSEcCtD
Fluvastatin—Visual impairment—Epirubicin—sarcoma	0.000247	0.00144	CcSEcCtD
Fluvastatin—Rash—Mitoxantrone—sarcoma	0.000247	0.00144	CcSEcCtD
Fluvastatin—Dermatitis—Mitoxantrone—sarcoma	0.000246	0.00144	CcSEcCtD
Fluvastatin—CYP2C8—testis—sarcoma	0.000246	0.00836	CbGeAlD
Fluvastatin—Headache—Mitoxantrone—sarcoma	0.000245	0.00143	CcSEcCtD
Fluvastatin—Erythema multiforme—Epirubicin—sarcoma	0.000243	0.00142	CcSEcCtD
Fluvastatin—Hypersensitivity—Etoposide—sarcoma	0.00024	0.0014	CcSEcCtD
Fluvastatin—Nausea—Vincristine—sarcoma	0.000239	0.00139	CcSEcCtD
Fluvastatin—Flushing—Epirubicin—sarcoma	0.000238	0.00139	CcSEcCtD
Fluvastatin—Cardiac disorder—Epirubicin—sarcoma	0.000238	0.00139	CcSEcCtD
Fluvastatin—Rhinitis—Doxorubicin—sarcoma	0.000238	0.00139	CcSEcCtD
Fluvastatin—Hepatitis—Doxorubicin—sarcoma	0.000237	0.00139	CcSEcCtD
Fluvastatin—Hypoaesthesia—Doxorubicin—sarcoma	0.000236	0.00138	CcSEcCtD
Fluvastatin—Pharyngitis—Doxorubicin—sarcoma	0.000236	0.00138	CcSEcCtD
Fluvastatin—Oedema peripheral—Doxorubicin—sarcoma	0.000234	0.00137	CcSEcCtD
Fluvastatin—Asthenia—Etoposide—sarcoma	0.000233	0.00136	CcSEcCtD
Fluvastatin—Connective tissue disorder—Doxorubicin—sarcoma	0.000233	0.00136	CcSEcCtD
Fluvastatin—Angiopathy—Epirubicin—sarcoma	0.000233	0.00136	CcSEcCtD
Fluvastatin—CYP2C8—liver—sarcoma	0.000233	0.00791	CbGeAlD
Fluvastatin—Nausea—Mitoxantrone—sarcoma	0.000232	0.00136	CcSEcCtD
Fluvastatin—Immune system disorder—Epirubicin—sarcoma	0.000232	0.00135	CcSEcCtD
Fluvastatin—Chills—Epirubicin—sarcoma	0.00023	0.00134	CcSEcCtD
Fluvastatin—Pruritus—Etoposide—sarcoma	0.00023	0.00134	CcSEcCtD
Fluvastatin—Arrhythmia—Epirubicin—sarcoma	0.000229	0.00134	CcSEcCtD
Fluvastatin—Visual impairment—Doxorubicin—sarcoma	0.000229	0.00134	CcSEcCtD
Fluvastatin—Alopecia—Epirubicin—sarcoma	0.000227	0.00132	CcSEcCtD
Fluvastatin—Mental disorder—Epirubicin—sarcoma	0.000225	0.00131	CcSEcCtD
Fluvastatin—Erythema multiforme—Doxorubicin—sarcoma	0.000225	0.00131	CcSEcCtD
Fluvastatin—Erythema—Epirubicin—sarcoma	0.000223	0.0013	CcSEcCtD
Fluvastatin—Diarrhoea—Etoposide—sarcoma	0.000223	0.0013	CcSEcCtD
Fluvastatin—CYP2B6—testis—sarcoma	0.000221	0.0075	CbGeAlD
Fluvastatin—Flushing—Doxorubicin—sarcoma	0.00022	0.00129	CcSEcCtD
Fluvastatin—Cardiac disorder—Doxorubicin—sarcoma	0.00022	0.00129	CcSEcCtD
Fluvastatin—Flatulence—Epirubicin—sarcoma	0.00022	0.00129	CcSEcCtD
Fluvastatin—Dysgeusia—Epirubicin—sarcoma	0.000219	0.00128	CcSEcCtD
Fluvastatin—CYP1A2—liver—sarcoma	0.000218	0.0074	CbGeAlD
Fluvastatin—Back pain—Epirubicin—sarcoma	0.000216	0.00126	CcSEcCtD
Fluvastatin—Angiopathy—Doxorubicin—sarcoma	0.000215	0.00126	CcSEcCtD
Fluvastatin—Dizziness—Etoposide—sarcoma	0.000215	0.00126	CcSEcCtD
Fluvastatin—CYP1A1—liver—sarcoma	0.000215	0.0073	CbGeAlD
Fluvastatin—Muscle spasms—Epirubicin—sarcoma	0.000215	0.00125	CcSEcCtD
Fluvastatin—Immune system disorder—Doxorubicin—sarcoma	0.000215	0.00125	CcSEcCtD
Fluvastatin—Chills—Doxorubicin—sarcoma	0.000213	0.00124	CcSEcCtD
Fluvastatin—Arrhythmia—Doxorubicin—sarcoma	0.000212	0.00124	CcSEcCtD
Fluvastatin—CYP3A5—liver—sarcoma	0.00021	0.00714	CbGeAlD
Fluvastatin—Alopecia—Doxorubicin—sarcoma	0.00021	0.00123	CcSEcCtD
Fluvastatin—CYP2B6—liver—sarcoma	0.000209	0.00709	CbGeAlD
Fluvastatin—Mental disorder—Doxorubicin—sarcoma	0.000208	0.00122	CcSEcCtD
Fluvastatin—Ill-defined disorder—Epirubicin—sarcoma	0.000207	0.00121	CcSEcCtD
Fluvastatin—CYP2C9—liver—sarcoma	0.000207	0.00702	CbGeAlD
Fluvastatin—Vomiting—Etoposide—sarcoma	0.000207	0.00121	CcSEcCtD
Fluvastatin—Erythema—Doxorubicin—sarcoma	0.000207	0.00121	CcSEcCtD
Fluvastatin—Rash—Etoposide—sarcoma	0.000205	0.0012	CcSEcCtD
Fluvastatin—Dermatitis—Etoposide—sarcoma	0.000205	0.0012	CcSEcCtD
Fluvastatin—Headache—Etoposide—sarcoma	0.000204	0.00119	CcSEcCtD
Fluvastatin—Flatulence—Doxorubicin—sarcoma	0.000204	0.00119	CcSEcCtD
Fluvastatin—Dysgeusia—Doxorubicin—sarcoma	0.000202	0.00118	CcSEcCtD
Fluvastatin—Malaise—Epirubicin—sarcoma	0.000201	0.00118	CcSEcCtD
Fluvastatin—Vertigo—Epirubicin—sarcoma	0.000201	0.00117	CcSEcCtD
Fluvastatin—Syncope—Epirubicin—sarcoma	0.0002	0.00117	CcSEcCtD
Fluvastatin—Leukopenia—Epirubicin—sarcoma	0.0002	0.00117	CcSEcCtD
Fluvastatin—Back pain—Doxorubicin—sarcoma	0.0002	0.00117	CcSEcCtD
Fluvastatin—Muscle spasms—Doxorubicin—sarcoma	0.000199	0.00116	CcSEcCtD
Fluvastatin—Loss of consciousness—Epirubicin—sarcoma	0.000196	0.00115	CcSEcCtD
Fluvastatin—Cough—Epirubicin—sarcoma	0.000195	0.00114	CcSEcCtD
Fluvastatin—Nausea—Etoposide—sarcoma	0.000193	0.00113	CcSEcCtD
Fluvastatin—Hypertension—Epirubicin—sarcoma	0.000193	0.00113	CcSEcCtD
Fluvastatin—Ill-defined disorder—Doxorubicin—sarcoma	0.000192	0.00112	CcSEcCtD
Fluvastatin—Chest pain—Epirubicin—sarcoma	0.00019	0.00111	CcSEcCtD
Fluvastatin—Arthralgia—Epirubicin—sarcoma	0.00019	0.00111	CcSEcCtD
Fluvastatin—Myalgia—Epirubicin—sarcoma	0.00019	0.00111	CcSEcCtD
Fluvastatin—Anxiety—Epirubicin—sarcoma	0.00019	0.00111	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000189	0.0011	CcSEcCtD
Fluvastatin—Discomfort—Epirubicin—sarcoma	0.000188	0.0011	CcSEcCtD
Fluvastatin—Malaise—Doxorubicin—sarcoma	0.000186	0.00109	CcSEcCtD
Fluvastatin—Vertigo—Doxorubicin—sarcoma	0.000186	0.00108	CcSEcCtD
Fluvastatin—Syncope—Doxorubicin—sarcoma	0.000185	0.00108	CcSEcCtD
Fluvastatin—Leukopenia—Doxorubicin—sarcoma	0.000185	0.00108	CcSEcCtD
Fluvastatin—Confusional state—Epirubicin—sarcoma	0.000184	0.00107	CcSEcCtD
Fluvastatin—Anaphylactic shock—Epirubicin—sarcoma	0.000182	0.00106	CcSEcCtD
Fluvastatin—Loss of consciousness—Doxorubicin—sarcoma	0.000182	0.00106	CcSEcCtD
Fluvastatin—Infection—Epirubicin—sarcoma	0.000181	0.00106	CcSEcCtD
Fluvastatin—Cough—Doxorubicin—sarcoma	0.00018	0.00105	CcSEcCtD
Fluvastatin—Shock—Epirubicin—sarcoma	0.000179	0.00105	CcSEcCtD
Fluvastatin—Nervous system disorder—Epirubicin—sarcoma	0.000179	0.00104	CcSEcCtD
Fluvastatin—Thrombocytopenia—Epirubicin—sarcoma	0.000179	0.00104	CcSEcCtD
Fluvastatin—Hypertension—Doxorubicin—sarcoma	0.000178	0.00104	CcSEcCtD
Fluvastatin—Skin disorder—Epirubicin—sarcoma	0.000177	0.00103	CcSEcCtD
Fluvastatin—Hyperhidrosis—Epirubicin—sarcoma	0.000176	0.00103	CcSEcCtD
Fluvastatin—Myalgia—Doxorubicin—sarcoma	0.000176	0.00103	CcSEcCtD
Fluvastatin—Arthralgia—Doxorubicin—sarcoma	0.000176	0.00103	CcSEcCtD
Fluvastatin—Chest pain—Doxorubicin—sarcoma	0.000176	0.00103	CcSEcCtD
Fluvastatin—Anxiety—Doxorubicin—sarcoma	0.000175	0.00102	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000175	0.00102	CcSEcCtD
Fluvastatin—Discomfort—Doxorubicin—sarcoma	0.000174	0.00102	CcSEcCtD
Fluvastatin—Anorexia—Epirubicin—sarcoma	0.000174	0.00102	CcSEcCtD
Fluvastatin—Confusional state—Doxorubicin—sarcoma	0.00017	0.000994	CcSEcCtD
Fluvastatin—Anaphylactic shock—Doxorubicin—sarcoma	0.000169	0.000985	CcSEcCtD
Fluvastatin—Infection—Doxorubicin—sarcoma	0.000168	0.000979	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000166	0.00097	CcSEcCtD
Fluvastatin—Shock—Doxorubicin—sarcoma	0.000166	0.000969	CcSEcCtD
Fluvastatin—Nervous system disorder—Doxorubicin—sarcoma	0.000165	0.000966	CcSEcCtD
Fluvastatin—Thrombocytopenia—Doxorubicin—sarcoma	0.000165	0.000965	CcSEcCtD
Fluvastatin—Insomnia—Epirubicin—sarcoma	0.000165	0.000963	CcSEcCtD
Fluvastatin—CYP1A1—lymph node—sarcoma	0.000165	0.0056	CbGeAlD
Fluvastatin—CYP2D6—testis—sarcoma	0.000164	0.00558	CbGeAlD
Fluvastatin—Skin disorder—Doxorubicin—sarcoma	0.000164	0.000957	CcSEcCtD
Fluvastatin—Paraesthesia—Epirubicin—sarcoma	0.000164	0.000956	CcSEcCtD
Fluvastatin—Hyperhidrosis—Doxorubicin—sarcoma	0.000163	0.000953	CcSEcCtD
Fluvastatin—Dyspnoea—Epirubicin—sarcoma	0.000163	0.000949	CcSEcCtD
Fluvastatin—Anorexia—Doxorubicin—sarcoma	0.000161	0.000939	CcSEcCtD
Fluvastatin—Dyspepsia—Epirubicin—sarcoma	0.000161	0.000937	CcSEcCtD
Fluvastatin—Decreased appetite—Epirubicin—sarcoma	0.000159	0.000926	CcSEcCtD
Fluvastatin—CYP3A4—liver—sarcoma	0.000158	0.00536	CbGeAlD
Fluvastatin—Gastrointestinal disorder—Epirubicin—sarcoma	0.000157	0.000919	CcSEcCtD
Fluvastatin—Fatigue—Epirubicin—sarcoma	0.000157	0.000918	CcSEcCtD
Fluvastatin—Pain—Epirubicin—sarcoma	0.000156	0.000911	CcSEcCtD
Fluvastatin—Constipation—Epirubicin—sarcoma	0.000156	0.000911	CcSEcCtD
Fluvastatin—CYP2D6—liver—sarcoma	0.000155	0.00527	CbGeAlD
Fluvastatin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000154	0.000898	CcSEcCtD
Fluvastatin—Insomnia—Doxorubicin—sarcoma	0.000153	0.000891	CcSEcCtD
Fluvastatin—Paraesthesia—Doxorubicin—sarcoma	0.000152	0.000885	CcSEcCtD
Fluvastatin—Dyspnoea—Doxorubicin—sarcoma	0.00015	0.000878	CcSEcCtD
Fluvastatin—Feeling abnormal—Epirubicin—sarcoma	0.00015	0.000878	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Epirubicin—sarcoma	0.000149	0.000871	CcSEcCtD
Fluvastatin—Dyspepsia—Doxorubicin—sarcoma	0.000149	0.000867	CcSEcCtD
Fluvastatin—Decreased appetite—Doxorubicin—sarcoma	0.000147	0.000857	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000146	0.000851	CcSEcCtD
Fluvastatin—Fatigue—Doxorubicin—sarcoma	0.000145	0.00085	CcSEcCtD
Fluvastatin—Urticaria—Epirubicin—sarcoma	0.000145	0.000846	CcSEcCtD
Fluvastatin—Pain—Doxorubicin—sarcoma	0.000144	0.000843	CcSEcCtD
Fluvastatin—Constipation—Doxorubicin—sarcoma	0.000144	0.000843	CcSEcCtD
Fluvastatin—Abdominal pain—Epirubicin—sarcoma	0.000144	0.000842	CcSEcCtD
Fluvastatin—Body temperature increased—Epirubicin—sarcoma	0.000144	0.000842	CcSEcCtD
Fluvastatin—Feeling abnormal—Doxorubicin—sarcoma	0.000139	0.000812	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Doxorubicin—sarcoma	0.000138	0.000806	CcSEcCtD
Fluvastatin—Hypersensitivity—Epirubicin—sarcoma	0.000134	0.000785	CcSEcCtD
Fluvastatin—Urticaria—Doxorubicin—sarcoma	0.000134	0.000783	CcSEcCtD
Fluvastatin—Abdominal pain—Doxorubicin—sarcoma	0.000133	0.000779	CcSEcCtD
Fluvastatin—Body temperature increased—Doxorubicin—sarcoma	0.000133	0.000779	CcSEcCtD
Fluvastatin—Asthenia—Epirubicin—sarcoma	0.000131	0.000764	CcSEcCtD
Fluvastatin—Pruritus—Epirubicin—sarcoma	0.000129	0.000753	CcSEcCtD
Fluvastatin—Diarrhoea—Epirubicin—sarcoma	0.000125	0.000729	CcSEcCtD
Fluvastatin—Hypersensitivity—Doxorubicin—sarcoma	0.000124	0.000726	CcSEcCtD
Fluvastatin—Asthenia—Doxorubicin—sarcoma	0.000121	0.000707	CcSEcCtD
Fluvastatin—Dizziness—Epirubicin—sarcoma	0.000121	0.000704	CcSEcCtD
Fluvastatin—Pruritus—Doxorubicin—sarcoma	0.000119	0.000697	CcSEcCtD
Fluvastatin—Vomiting—Epirubicin—sarcoma	0.000116	0.000677	CcSEcCtD
Fluvastatin—Diarrhoea—Doxorubicin—sarcoma	0.000115	0.000674	CcSEcCtD
Fluvastatin—Rash—Epirubicin—sarcoma	0.000115	0.000671	CcSEcCtD
Fluvastatin—Dermatitis—Epirubicin—sarcoma	0.000115	0.000671	CcSEcCtD
Fluvastatin—Headache—Epirubicin—sarcoma	0.000114	0.000667	CcSEcCtD
Fluvastatin—Dizziness—Doxorubicin—sarcoma	0.000112	0.000652	CcSEcCtD
Fluvastatin—Nausea—Epirubicin—sarcoma	0.000108	0.000633	CcSEcCtD
Fluvastatin—Vomiting—Doxorubicin—sarcoma	0.000107	0.000627	CcSEcCtD
Fluvastatin—Rash—Doxorubicin—sarcoma	0.000106	0.000621	CcSEcCtD
Fluvastatin—Dermatitis—Doxorubicin—sarcoma	0.000106	0.000621	CcSEcCtD
Fluvastatin—Headache—Doxorubicin—sarcoma	0.000106	0.000617	CcSEcCtD
Fluvastatin—Nausea—Doxorubicin—sarcoma	0.0001	0.000585	CcSEcCtD
